At AMP 2022, Immunexpress launches rapid test for sepsis requiring two minutes hands-on time

AMP 2020 Annual Meeting and Expo

From Leo O’Connor of At the Association for Molecular Pathology annual meeting and exposition this week, Immunexpress launched a rapid molecular diagnostic test that could enable ruling in or ruling out sepsis in one hour. The SeptiCyte Rapid test is different from almost all other sepsis tests on the market by means of its operation directly…

Read More

A multi-site study confirms the use of undiluted EDTA blood for the SeptiCyte RAPID sepsis assay

Cision PR Newswire

Data Validating EDTA Blood as Sample Type for SeptiCyte® RAPID Presented at the Association for Molecular Pathology 2022 Annual Meeting SEATTLE and BRISBANE, Australia, Nov. 3, 2022 /PRNewswire/ — Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, announced today the presentation of an abstract at the Association for Molecular Pathology 2022 Annual Meeting…

Read More